VEEV Veeva Systems (VEEV) Q4 FY25 earnings call
Veeva Systems concluded FY25 with robust Q4 results, surpassing guidance across key financial metrics, driven by strong execution and product innovation. The company secured a significant 'all-in' clinical platform deal with a top 20 pharma, highlighting a trend towards integrated solutions. While preparing for future growth with a 2030 revenue target of $6 billion and new market expansions, Veeva navigates a slight deceleration in subscription growth for FY26, largely due to prior-year outperformance and FX headwinds, maintaining focus on product excellence and customer-friendly transitions f
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
VEEV operating KPIs by quarter
| KPI | Jul 2025 Q2 FY26 | Oct 2025 Q3 FY26 | Apr 2026 Q1 FY27 | Jul 2026 Q2 FY27 | Change vs prior quarter |
|---|---|---|---|---|---|
| Live customers in CRM | 100So now that's gone with Salesforce since we've moved to Vault, and we have 100 live customers in CRM.Source: earnings call transcript | 115And then, Brian, 115 customers live on Vault CRM, including I think some top 20s kind of in the motions.Source: earnings call transcript | 150+We have customers now, over 150 customers live on Vault CRM.Source: earnings call transcript | 180+We have over 180 customers live.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.